Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""VIRAL nonstructural proteins"" wg kryterium: Temat


Tytuł:
Study of drug resistance-associated genetic mutations, and phylo-genetic analysis of HCV in the Province of Sindh, Pakistan.
Autorzy:
Faiz S; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, National Institute of Virology, University of Karachi, Karachi, 75270, Pakistan.
Irfan M; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, Jamil-ur-Rahman Center for Genome Research, University of Karachi, Karachi, 75270, Pakistan.
Farooq S; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, National Institute of Virology, University of Karachi, Karachi, 75270, Pakistan. .
Khan IA; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, Jamil-ur-Rahman Center for Genome Research, University of Karachi, Karachi, 75270, Pakistan. .
Iqbal H; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, National Institute of Virology, University of Karachi, Karachi, 75270, Pakistan.
Wahab AT; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan.
Shakeel M; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, Jamil-ur-Rahman Center for Genome Research, University of Karachi, Karachi, 75270, Pakistan.
Gong P; Wuhan Institute of Virology, Chinese Academy of Sciences, No.44 Xiao Hong Shan, Wuhan, 430071, Hubei, China.
Iftner T; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, National Institute of Virology, University of Karachi, Karachi, 75270, Pakistan.; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital and Medical Faculty, Eberhard Karls University, Tuebingen, Germany.
Choudhary MI; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, National Institute of Virology, University of Karachi, Karachi, 75270, Pakistan. .; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, Jamil-ur-Rahman Center for Genome Research, University of Karachi, Karachi, 75270, Pakistan. .; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan. .; Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry, University of Karachi, Karachi, 75270, Pakistan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jul 27; Vol. 13 (1), pp. 12213. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents*/pharmacology
Antiviral Agents*/therapeutic use
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Humans ; Pakistan/epidemiology ; Phylogeny ; Hepacivirus ; Genotype ; Drug Resistance, Viral/genetics ; Viral Nonstructural Proteins/genetics ; Mutation
Czasopismo naukowe
Tytuł:
Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
Autorzy:
Hu LC; Department of Oncology, Affiliated Hospital of Weifang Medical University, Weifang, China.
Ding CH; Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Li HY; Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Li ZZ; Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Chen Y; School of Pharmacy, Weifang Medical University, Weifang, China.
Li LP; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin, China.
Li WZ; School of Pharmacy, Weifang Medical University, Weifang, China.
Liu WS; Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang, China.
Pokaż więcej
Źródło:
Journal of food biochemistry [J Food Biochem] 2022 May; Vol. 46 (5), pp. e14085. Date of Electronic Publication: 2022 Feb 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents*/chemistry
Antiviral Agents*/pharmacology
Biological Products*/pharmacology
Endoribonucleases*/antagonists & inhibitors
SARS-CoV-2*/drug effects
Viral Nonstructural Proteins*/antagonists & inhibitors
Humans ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; COVID-19 Drug Treatment
Czasopismo naukowe
Tytuł:
3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors.
Autorzy:
Bobileva O; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Bobrovs R; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Sirma EE; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Kanepe I; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Bula AL; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Patetko L; Faculty of Biology, University of Latvia, LV-1004 Riga, Latvia.
Ramata-Stunda A; Faculty of Biology, University of Latvia, LV-1004 Riga, Latvia.
Grinberga S; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Jirgensons A; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Jaudzems K; Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jan 12; Vol. 28 (2). Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Methyltransferases*/antagonists & inhibitors
SARS-CoV-2*/drug effects
Antiviral Agents*/pharmacology
Methylation ; RNA, Messenger/genetics ; RNA, Viral/genetics ; S-Adenosylmethionine/chemistry ; Viral Nonstructural Proteins/metabolism
Czasopismo naukowe
Tytuł:
Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture.
Autorzy:
Wang X; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
Sacramento CQ; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology for Innovation on Diseases of Neglected Population (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
Jockusch S; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemistry, Columbia University, New York, NY, 10027, USA.
Chaves OA; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology for Innovation on Diseases of Neglected Population (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
Tao C; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
Fintelman-Rodrigues N; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology for Innovation on Diseases of Neglected Population (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
Chien M; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
Temerozo JR; Laboratory on Thymus Research, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.; National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
Li X; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
Kumar S; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
Xie W; Laboratory of Structural Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.
Patel DJ; Laboratory of Structural Biology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.
Meyer C; Laboratory of RNA Molecular Biology, Rockefeller University, New York, NY, 10065, USA.
Garzia A; Laboratory of RNA Molecular Biology, Rockefeller University, New York, NY, 10065, USA.
Tuschl T; Laboratory of RNA Molecular Biology, Rockefeller University, New York, NY, 10065, USA.
Bozza PT; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil.
Russo JJ; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA.; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA.
Souza TML; Laboratory of Immunopharmacology, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil. .; National Institute for Science and Technology for Innovation on Diseases of Neglected Population (INCT/IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, RJ, Brazil. .
Ju J; Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY, 10027, USA. .; Department of Chemical Engineering, Columbia University, New York, NY, 10027, USA. .; Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, 10032, USA. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Feb 22; Vol. 5 (1), pp. 154. Date of Electronic Publication: 2022 Feb 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Drug Treatment*
Antiviral Agents/*pharmacology
Exonucleases/*antagonists & inhibitors
RNA-Dependent RNA Polymerase/*antagonists & inhibitors
SARS-CoV-2/*drug effects
Viral Nonstructural Proteins/*antagonists & inhibitors
Amino Acid Sequence ; Anilides/pharmacology ; Animals ; Base Sequence ; Benzimidazoles/pharmacology ; COVID-19/virology ; Cell Line, Tumor ; Chlorocebus aethiops ; Drug Synergism ; Exonucleases/genetics ; Exonucleases/metabolism ; Humans ; Proline/pharmacology ; Pyrrolidines/pharmacology ; RNA, Viral/genetics ; RNA, Viral/metabolism ; RNA-Dependent RNA Polymerase/genetics ; RNA-Dependent RNA Polymerase/metabolism ; SARS-CoV-2/genetics ; SARS-CoV-2/physiology ; Valine/pharmacology ; Vero Cells ; Viral Nonstructural Proteins/genetics ; Viral Nonstructural Proteins/metabolism ; Virus Replication/drug effects ; Virus Replication/genetics
Czasopismo naukowe
Tytuł:
Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula : A Structural Perspective.
Autorzy:
Patil VS; ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India.
Harish DR; ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India.
Vetrivel U; ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India.; ICMR-National Institute for Research in Tuberculosis, Chetpet, Chennai 600031, India.
Roy S; ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India.
Deshpande SH; ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India.; Regional Centre for Biotechnology, NCR-Biotech Science Cluster, Faridabad 121001, India.
Hegde HV; ICMR-National Institute of Traditional Medicine, Nehru Nagar, Belagavi 590010, India.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Feb 05; Vol. 27 (3). Date of Electronic Publication: 2022 Feb 05.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*pharmacology
Hepacivirus/*enzymology
Serine Proteases/*chemistry
Serine Proteases/*metabolism
Tannins/*pharmacology
Terminalia/*chemistry
Viral Nonstructural Proteins/*chemistry
Viral Nonstructural Proteins/*metabolism
Antiviral Agents/adverse effects ; Antiviral Agents/chemistry ; Benzopyrans/pharmacology ; Catalytic Domain ; Computer Simulation ; Glucosides/pharmacology ; Hepacivirus/drug effects ; Hydrolyzable Tannins/pharmacology ; Models, Molecular ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Network Pharmacology ; Plant Extracts/pharmacology ; Protein Binding ; Protein Conformation ; Tannins/adverse effects ; Tannins/chemistry ; Viral Nonstructural Proteins/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets.
Autorzy:
Ricci F; Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, 98166 Messina, Italy.
Gitto R; Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, 98166 Messina, Italy.
Pitasi G; Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, 98166 Messina, Italy.
De Luca L; Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, 98166 Messina, Italy.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2022 Mar 22; Vol. 12 (4). Date of Electronic Publication: 2022 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents*/chemistry
RNA Helicases*/antagonists & inhibitors
SARS-CoV-2*/drug effects
Viral Nonstructural Proteins*/antagonists & inhibitors
Binding Sites ; COVID-19 ; Humans ; Pandemics
Czasopismo naukowe
Tytuł:
A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response.
Autorzy:
Gao Z; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Zhang X; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Zhang L; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Wu S; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Ma J; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Wang F; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Zhou Y; Bioinformatics and Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.
Dai X; Department of Physiology and Biophysics, Case Western Reserve University, School of Medicine, Cleveland, Ohio, United States of America.
Bullitt E; Department of Physiology & Biophysics, Boston University School of Medicine, Boston, Massachusetts, United States of America.
Du Y; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Guo JT; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Chang J; Baruch S. Blumberg Institute, Doylestown, Pennsylvania, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Jan 21; Vol. 18 (1), pp. e1010271. Date of Electronic Publication: 2022 Jan 21 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*pharmacology
Benzodiazepines/*pharmacology
Viral Nonstructural Proteins/*antagonists & inhibitors
Virus Replication/*drug effects
Yellow fever virus/*drug effects
Cell Line ; DEAD Box Protein 58/immunology ; Humans ; Immunity, Innate/immunology ; Viral Nonstructural Proteins/drug effects ; Yellow Fever/immunology ; Yellow fever virus/immunology
Czasopismo naukowe
Tytuł:
Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
Autorzy:
Wahaab A; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.
Mustafa BE; Sub Campus Toba Tek Singh, University of Agriculture, Faisalabad 36050, Pakistan.
Hameed M; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.; Department of Biomedical Sciences and Pathobiology, College of Veterinary Medicine, Virginia Polytechnic Institute, State University, Fralin Life Sciences Building, 360 W Campus Blacksburg, Blacksburg, VA 24061, USA.
Stevenson NJ; Royal College of Surgeons in Ireland, Medical University of Bahrain, Busaiteen, Adliya 15503, Bahrain.; Viral Immunology Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland.
Anwar MN; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.
Liu K; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.
Wei J; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.
Qiu Y; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.
Ma Z; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai 200241, China.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Dec 28; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Drug Discovery*
Antiviral Agents/*pharmacology
Flavivirus/*enzymology
Flavivirus Infections/*virology
Peptide Hydrolases/*metabolism
RNA Helicases/*metabolism
Serine Endopeptidases/*metabolism
Viral Nonstructural Proteins/*metabolism
Animals ; Dengue Virus ; Drug Tapering ; Encephalitis Virus, Japanese ; Flavivirus/genetics ; Humans ; Peptide Hydrolases/genetics ; Polyproteins ; RNA Helicases/genetics ; Serine Endopeptidases/genetics ; Viral Nonstructural Proteins/genetics ; Viral Replicase Complex Proteins ; West Nile virus ; Yellow fever virus ; Zika Virus
Czasopismo naukowe
Tytuł:
In silico identification of novel SARS-COV-2 2'-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches.
Autorzy:
El Hassab MA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Egypt.
Ibrahim TM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
Al-Rashood ST; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alharbi A; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Eskandrani RO; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Eldehna WM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt.
Pokaż więcej
Źródło:
Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 727-736.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*chemistry
Enzyme Inhibitors/*chemistry
SARS-CoV-2/*enzymology
Viral Nonstructural Proteins/*chemistry
Adenosine/analogs & derivatives ; Adenosine/chemistry ; Adenosine/metabolism ; Antiviral Agents/metabolism ; Binding Sites ; Crystallography, X-Ray ; Databases, Pharmaceutical ; Databases, Protein ; Drug Stability ; Enzyme Inhibitors/metabolism ; High-Throughput Screening Assays ; Humans ; Kinetics ; Methyltransferases ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Protein Binding ; Protein Conformation, alpha-Helical ; Protein Conformation, beta-Strand ; Protein Interaction Domains and Motifs ; SARS-CoV-2/chemistry ; Thermodynamics ; Viral Nonstructural Proteins/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors.
Autorzy:
Nasr T; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain-Helwan, Cairo 11795, Egypt.; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, MTI University, Cairo 12055, Egypt.
Aboshanab AM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain-Helwan, Cairo 11795, Egypt.
Mpekoulis G; Molecular Virology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece.
Drakopoulos A; Department of Chemistry and Molecular Biology, University of Gothenburg, SE-412 96 Gothenburg, Sweden.
Vassilaki N; Molecular Virology Laboratory, Hellenic Pasteur Institute, 11521 Athens, Greece.
Zoidis G; Department of Pharmacy, Division of Pharmaceutical Chemistry, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece.
Abouzid KAM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
Zaghary W; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain-Helwan, Cairo 11795, Egypt.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Dec 12; Vol. 14 (12). Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents*/pharmacology
Enzyme Inhibitors*/pharmacology
Hepacivirus*/drug effects
Humans ; Hepatitis C, Chronic ; Quinazolinones/pharmacology ; Structure-Activity Relationship ; Viral Nonstructural Proteins ; Virus Replication
Czasopismo naukowe
Tytuł:
Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3.
Autorzy:
Bakovic A; National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, VA 20110, USA.
Bhalla N; National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, VA 20110, USA.
Alem F; National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, VA 20110, USA.
Campbell C; DCE Consulting, Vienna, VA 22181, USA.
Zhou W; School of Systems Biology, George Mason University, Manassas, VA 20110, USA.
Narayanan A; National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, VA 20110, USA.; American Type Culture Collection, Manassas, VA 20110, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Aug 03; Vol. 13 (8). Date of Electronic Publication: 2021 Aug 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Antiviral Agents/*pharmacology
Encephalitis Virus, Venezuelan Equine/*drug effects
Host Microbial Interactions/*drug effects
Viral Nonstructural Proteins/*antagonists & inhibitors
Virus Replication/*drug effects
Animals ; Cell Line ; Chlorocebus aethiops ; Encephalitis Virus, Venezuelan Equine/genetics ; Horses ; Humans ; Proteome ; Vero Cells ; Viral Nonstructural Proteins/classification ; Viral Nonstructural Proteins/genetics
Czasopismo naukowe
Tytuł:
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.
Autorzy:
Armstrong LA; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Lange SM; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Dee Cesare V; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Matthews SP; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Nirujogi RS; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Cole I; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Hope A; Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Cunningham F; Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Toth R; MRC Reagents and Services, University of Dundee, Dundee, Scotland, United Kingdom.
Mukherjee R; Institute of Biochemistry II, Goethe University Frankfurt Medical Faculty, University Hospital, Frankfurt am Main, Germany.; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.
Bojkova D; Institute of Medical Virology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Gruber F; National Phenotypic Screening Centre, University of Dundee, Dundee, Scotland, United Kingdom.
Gray D; Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Wyatt PG; Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Cinatl J; Institute of Medical Virology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Dikic I; Institute of Biochemistry II, Goethe University Frankfurt Medical Faculty, University Hospital, Frankfurt am Main, Germany.; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt am Main, Germany.; Max Planck Institute of Biophysics, Frankfurt am Main, Germany.
Davies P; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Kulathu Y; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee, Scotland, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 16; Vol. 16 (7), pp. e0253364. Date of Electronic Publication: 2021 Jul 16 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*pharmacology
Protease Inhibitors/*pharmacology
RNA-Dependent RNA Polymerase/*antagonists & inhibitors
Single-Chain Antibodies/*pharmacology
Viral Nonstructural Proteins/*antagonists & inhibitors
A549 Cells ; Antigen-Antibody Complex ; Humans ; Inhibitory Concentration 50 ; RNA-Dependent RNA Polymerase/immunology ; RNA-Dependent RNA Polymerase/metabolism ; Single-Chain Antibodies/immunology ; Viral Nonstructural Proteins/immunology ; Viral Nonstructural Proteins/metabolism
Czasopismo naukowe
Tytuł:
Dual Effect of Organogermanium Compound THGP on RIG-I-Mediated Viral Sensing and Viral Replication during Influenza a Virus Infection.
Autorzy:
Baidya S; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Nishimoto Y; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Sato S; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Shimada Y; Asai Germanium Research Institute Co., Ltd. Suzuranoka, Hakodate 042-0958, Japan.
Sakurai N; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Nonaka H; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Noguchi K; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Kido M; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Tadano S; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Ishikawa K; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Li K; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Okubo A; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Yamada T; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Orba Y; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.
Sasaki M; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.
Sawa H; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.; Global Virus Network, Baltimore, MD 21201, USA.
Miyamoto H; Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.
Takada A; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.; Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.
Nakamura T; Asai Germanium Research Institute Co., Ltd. Suzuranoka, Hakodate 042-0958, Japan.
Takaoka A; Division of Signaling in Cancer and Immunology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.; Molecular Medical Biochemistry Unit, Biological Chemistry and Engineering Course, Graduate School of Chemical Sciences and Engineering, Hokkaido University, Sapporo 060-0815, Japan.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Aug 24; Vol. 13 (9). Date of Electronic Publication: 2021 Aug 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*pharmacology
Immunity, Innate/*drug effects
Influenza A virus/*physiology
Organometallic Compounds/*pharmacology
Receptors, Retinoic Acid/*genetics
Viral Nonstructural Proteins/*genetics
Virus Replication/*drug effects
A549 Cells ; Animals ; Antiviral Agents/metabolism ; Antiviral Agents/therapeutic use ; Host-Pathogen Interactions/drug effects ; Humans ; Influenza A virus/immunology ; Influenza A virus/pathogenicity ; Interferon Type I/immunology ; Interferon Type I/metabolism ; Mice ; Organometallic Compounds/metabolism ; Organometallic Compounds/therapeutic use ; Orthomyxoviridae Infections/drug therapy ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/virology ; RAW 264.7 Cells ; RNA, Viral/genetics ; RNA, Viral/metabolism ; Receptors, Retinoic Acid/immunology ; Viral Nonstructural Proteins/metabolism ; Virus Replication/genetics
Czasopismo naukowe
Tytuł:
Computational Approaches to Discover Novel Natural Compounds for SARS-CoV-2 Therapeutics.
Autorzy:
Rampogu S; Division of Life Sciences, Research Institute of Natural Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828, South Korea.
Lee G; Division of Life Sciences, Research Institute of Natural Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828, South Korea.
Kulkarni AM; Division of Life Sciences, Research Institute of Natural Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828, South Korea.
Kim D; Division of Life Sciences, Research Institute of Natural Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828, South Korea.
Yoon S; Division of Life Sciences, Research Institute of Natural Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828, South Korea.
Kim MO; Division of Life Science and Applied Life Science, College of Natural Sciences, Gyeongsang National University, Jinju, South Korea.
Lee KW; Division of Life Sciences, Research Institute of Natural Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828, South Korea.
Pokaż więcej
Źródło:
ChemistryOpen [ChemistryOpen] 2021 May; Vol. 10 (5), pp. 593-599.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*metabolism
Biological Products/*metabolism
Enzyme Inhibitors/*metabolism
SARS-CoV-2/*drug effects
Viral Nonstructural Proteins/*metabolism
Antiviral Agents/pharmacokinetics ; Biological Products/pharmacokinetics ; Drug Discovery ; Enzyme Inhibitors/pharmacokinetics ; Methyltransferases ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Protein Binding ; Software ; Viral Nonstructural Proteins/pharmacokinetics
Czasopismo naukowe
Tytuł:
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
Autorzy:
Choi R; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.
Zhou M; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, United States of America.
Shek R; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, WA, United States of America.
Wilson JW; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, United States of America.
Tillery L; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, WA, United States of America.
Craig JK; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, WA, United States of America.
Salukhe IA; Department of Microbiology, University of Washington School of Medicine, Seattle, WA, United States of America.
Hickson SE; Department of Microbiology, University of Washington School of Medicine, Seattle, WA, United States of America.
Kumar N; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, United States of America.
James RM; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, United States of America.
Buchko GW; Earth and Biological Sciences Directorate, Pacific Northwest National Laboratory (PNNL), Richland, WA, United States of America.; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, WA, United States of America.; School of Molecular Bioscience, Washington State University, Pullman, WA, United States of America.
Wu R; Bioenergy and Biome Sciences, Los Alamos National Laboratory (LANL), Los Alamos, NM, United States of America.
Huff S; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.
Nguyen TT; Calibr, a division of The Scripps Research Institute, La Jolla, CA, United States of America.
Hurst BL; Institute for Antiviral Research, Utah State University, Logan, UT, United States of America.
Cherry S; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.
Barrett LK; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, WA, United States of America.
Hyde JL; Department of Microbiology, University of Washington School of Medicine, Seattle, WA, United States of America.
Van Voorhis WC; Division of Allergy and Infectious Diseases, Department of Medicine, Center for Emerging and Reemerging Infectious Diseases (CERID), University of Washington School of Medicine, Seattle, WA, United States of America.; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, WA, United States of America.; Department of Microbiology, University of Washington School of Medicine, Seattle, WA, United States of America.; Department of Global Health, University of Washington, Seattle, WA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Apr 22; Vol. 16 (4), pp. e0250019. Date of Electronic Publication: 2021 Apr 22 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Drug Repositioning*/methods
COVID-19 Drug Treatment*
Antiviral Agents/*pharmacology
Endoribonucleases/*antagonists & inhibitors
SARS-CoV-2/*drug effects
Small Molecule Libraries/*pharmacology
Viral Nonstructural Proteins/*antagonists & inhibitors
Animals ; Antiviral Agents/chemistry ; COVID-19/virology ; Caco-2 Cells ; Chlorocebus aethiops ; Endoribonucleases/metabolism ; High-Throughput Screening Assays/methods ; Humans ; Molecular Docking Simulation ; SARS-CoV-2/metabolism ; Small Molecule Libraries/chemistry ; Vero Cells ; Viral Nonstructural Proteins/metabolism
Czasopismo naukowe
Tytuł:
Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs.
Autorzy:
Kim HJ; Department of Molecular Biology, College of Natural Sciences, Pusan National University, Jangjeon-dong, Geumjeong-gu, Busan 46241, Korea.
Jeong MS; Institute for Plastic Information and Energy Materials and Sustainable Utilization of Photovoltaic Energy Research Center, Pusan National University, Jangjeon-dong, Geumjeong-gu, Busan 46241, Korea.
Jang SB; Department of Molecular Biology, College of Natural Sciences, Pusan National University, Jangjeon-dong, Geumjeong-gu, Busan 46241, Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 19; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antiviral Agents/*chemistry
Antiviral Agents/*pharmacology
Viral Nonstructural Proteins/*metabolism
Animals ; Humans ; Influenza A virus/drug effects ; Influenza A virus/genetics ; Influenza, Human/virology ; Structure-Activity Relationship ; Viral Nonstructural Proteins/genetics ; Virus Replication/drug effects ; Virus Replication/genetics ; Virus Replication/physiology
Czasopismo naukowe
Tytuł:
Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C.
Autorzy:
Ahmed HR; Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt.
Waly NGFM; Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt.
Abd El-Baky RM; Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt.; Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia, Egypt.
Yahia R; Department of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, Minia, Egypt.
Hetta HF; Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.; Department of Medical Microbiology and Immunology, Faculty of Medicine, Merit University, Sohag, Egypt.
Elsayed AM; Tropical Medicine and Gastroenterology, Faculty of Medicine, Minia University, Minia, Egypt.
Ibrahem RA; Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Apr 15; Vol. 16 (4), pp. e0249770. Date of Electronic Publication: 2021 Apr 15 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Mutation*
Antiviral Agents/*therapeutic use
Hepacivirus/*genetics
Hepatitis C, Chronic/*drug therapy
Viral Nonstructural Proteins/*antagonists & inhibitors
Adult ; Aged ; Drug Resistance, Viral ; Egypt ; Female ; Hepacivirus/isolation & purification ; Hepacivirus/pathogenicity ; Hepatitis C, Chronic/genetics ; Hepatitis C, Chronic/virology ; Humans ; Immunity, Innate ; Male ; Middle Aged ; Treatment Outcome ; Viral Nonstructural Proteins/genetics ; Young Adult
Czasopismo naukowe
Tytuł:
Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
Autorzy:
Mohammad A; Department of Biochemistry and Molecular Biology 1, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Alshawaf E; Department of Biochemistry and Molecular Biology 1, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Marafie SK; Department of Biochemistry and Molecular Biology 1, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Abu-Farha M; Department of Biochemistry and Molecular Biology 1, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Al-Mulla F; Department of Genetics and Bioinformatics 2, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Abubaker J; Department of Biochemistry and Molecular Biology 1, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2021 Apr 14; Vol. 11 (4). Date of Electronic Publication: 2021 Apr 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19 Drug Treatment*
Antiviral Agents/*pharmacology
Biological Products/*pharmacology
SARS-CoV-2/*drug effects
Viral Nonstructural Proteins/*metabolism
Viral Regulatory and Accessory Proteins/*metabolism
Antiviral Agents/chemistry ; Biological Products/chemistry ; Drug Discovery ; Humans ; Methyltransferases ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Protein Interaction Maps/drug effects ; SARS-CoV-2/metabolism ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Regulatory and Accessory Proteins/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro.
Autorzy:
Boccuto A; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Dragoni F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Picarazzi F; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Lai A; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
Della Ventura C; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
Veo C; Clinical Pathology Analysis Laboratory ASL Taranto, 74023 Taranto, Italy.
Giammarino F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Saladini F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Zehender G; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, 20157 Milan, Italy.
Zazzi M; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Mori M; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Vicenti I; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 06; Vol. 22 (5). Date of Electronic Publication: 2021 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Amino Acid Substitution*
Point Mutation*
Antiviral Agents/*pharmacology
RNA-Dependent RNA Polymerase/*antagonists & inhibitors
Sofosbuvir/*pharmacology
Viral Nonstructural Proteins/*antagonists & inhibitors
Zika Virus/*drug effects
Animals ; Antiviral Agents/therapeutic use ; Binding Sites ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Chlorocebus aethiops ; Humans ; Inhibitory Concentration 50 ; Liver Neoplasms/pathology ; Models, Molecular ; Molecular Dynamics Simulation ; Protein Binding ; Protein Conformation ; RNA, Viral/biosynthesis ; RNA, Viral/genetics ; RNA-Dependent RNA Polymerase/genetics ; RNA-Dependent RNA Polymerase/metabolism ; Selection, Genetic ; Sofosbuvir/therapeutic use ; Vero Cells ; Viral Nonstructural Proteins/genetics ; Viral Nonstructural Proteins/metabolism ; Virus Replication/drug effects ; Zika Virus/enzymology ; Zika Virus/genetics
Czasopismo naukowe
Tytuł:
Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
Autorzy:
Freidel MR; Department of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Armen RS; Department of Pharmaceutical Sciences, College of Pharmacy, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Feb 17; Vol. 16 (2), pp. e0246181. Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*pharmacology
COVID-19/*virology
Coronavirus RNA-Dependent RNA Polymerase/*metabolism
Methyltransferases/*metabolism
RNA Helicases/*metabolism
SARS-CoV-2/*drug effects
Viral Nonstructural Proteins/*metabolism
Allosteric Site ; Binding Sites ; COVID-19/metabolism ; Computational Biology/methods ; Coronavirus 3C Proteases/antagonists & inhibitors ; Coronavirus 3C Proteases/chemistry ; Coronavirus 3C Proteases/metabolism ; Coronavirus RNA-Dependent RNA Polymerase/antagonists & inhibitors ; Coronavirus RNA-Dependent RNA Polymerase/chemistry ; Humans ; Methyltransferases/antagonists & inhibitors ; Methyltransferases/chemistry ; Models, Molecular ; Molecular Targeted Therapy ; Protein Binding ; RNA Helicases/antagonists & inhibitors ; RNA Helicases/chemistry ; RNA-Dependent RNA Polymerase/metabolism ; SARS-CoV-2/metabolism ; Viral Nonstructural Proteins/antagonists & inhibitors ; Viral Nonstructural Proteins/chemistry ; Virus Replication/drug effects ; COVID-19 Drug Treatment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies